OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE (S1P) AGONISTS
申请人:Ahmed Mahmood
公开号:US20100113528A1
公开(公告)日:2010-05-06
The present invention provides compounds of formula (I) or salts thereof:
having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors.
Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
申请人:Glaxo Group Limited
公开号:US08324254B2
公开(公告)日:2012-12-04
The present invention provides compounds of formula (I) or salts thereof:
having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors.
[EN] OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE (S1P) AGONISTS<br/>[FR] DÉRIVÉS D'INDAZOLE SUBSTITUÉS PAR OXADIAZOLE, DESTINÉS À ÊTRE UTILISÉS COMME AGONISTES DE LA SPHINGOSINE 1-PHOSPHATE (S1P)
申请人:GLAXO GROUP LTD
公开号:WO2008128951A1
公开(公告)日:2008-10-30
[EN] The present invention provides compounds of formula (I) or salts thereof, having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors. [FR] La présente invention porte sur des composés de formule (I) ou des sels de ceux-ci, ayant une activité pharmacologique, sur des procédés pour leur préparation, sur des compositions pharmaceutiques les contenant, et sur leur utilisation dans le traitement de divers troubles liés aux récepteurs de S1P1.